 2
中文摘要 
由於鈦金屬具質輕、低彈性係數和生物惰性，故近年逐漸取代其他的金屬材料成為骨
科及齒科植入材的首選。然而，如何使骨細胞在初期及後續生長能與鈦金屬間形成一堅固
的交織乃是一個高度被重視及可發展的空間。本研究重點在探討鈦金屬微弧氧化處理之二
氧化鈦鍍層生長機制，並進行氧化層微觀組織及骨細胞相容性之鑑定，期望能提升鈦金屬
骨科植入材的骨細胞相容性，縮短植入材與患者自體骨骨整合時間，降低鈦金屬植入材的
製造成本。研究結果顯示：微弧氧化處理所得氧化層微結構明顯受到放電電壓和微弧處理
時間影響。較低放電電壓和較短微弧處理時間會生成銳鈦礦相為主之二氧化鈦鍍層；較高
放電電壓和較長微弧處理時間則易生成金紅石相結構為主之 TiO2 鍍層。進一步由電化學開
路電位、循環伏安和交流阻抗分析可得知；經微弧氧化處理所得 TiO2 鍍層之抗腐蝕能力明
顯優於 β-Ti 基材，且經微弧氧化處理後之 TiO2 鍍層試片其金屬釋出量較 β-Ti 基材少，說明
了 TiO2 鍍層可減少鈦金屬離子的析出且具良好耐蝕性。而在體外的骨細胞相容性表現上，
經微弧氧化所得之 TiO2 鍍層明顯優於未經微弧氧化處理之 β-Ti 基材；其中金紅石相結構鍍
層又比銳鈦礦相結構鍍層具有更高骨細胞相容性及造骨特性。以上結果顯示，微弧氧化處
理所得 TiO2 鍍層確實可提供骨母細胞較優異的生長條件，為骨科植入材表面改質提供另一
選擇方案。 
關鍵詞：微弧氧化、鈦、二氧化鈦、骨整合、體外、骨細胞、電化學。 
 
英文摘要 
Due to the heritage of light-weight, low elastic modulus and bioinertness, titanium metal has 
been the first priority candidate material for orthopedic and dental applications though, the 
titanium implant surface is eagerly to require a capability of rapid growth of osteoblast cell and to 
the end a firm network between the tissue cell and the implant surface. In this research, micro-arc 
oxidation (MAO, or plasma electrolytic oxidation, PEO) technology was employed on titanium 
alloy to improve the cell compatibility of titanium implant. Growth mechanism of the MAO-TiO2 
was revealed, microstructure of the grown layer was characterized and cell compatibility was 
tested. Ultimately, rapid fusion of osseointegration between human bone cell and the titanium 
implant is expected to be achieved. Experimental results show that crystal structure of the MAO 
layer is strongly influenced by the applied voltage (during MAO treatment), where anatase phase 
was formed under low voltage instead of rutile phase under high voltage. By comparison, the 
MAO treated titanium exhibited superior corrosion resistance and less amount of metal was 
released than bare titanium. The in-vitro test result show that the TiO2 layer of MAO treated 
titanium presented high osteoblast cell compatibility and excellent osseointegration. In addition, 
the rutile-TiO2 rich MAO layer exhibited better osteoblast cell compatibility and osseointegration 
performance than the anatase-TiO2 rich MAO layer. Results of this study may provide an 
alternative for osteoblast compatible surface modification for titanium implant. 
 4
前言 
有鑑於鈦金屬表面的天然氧化層與骨細胞雖具良好的生物相容性，但呈非晶質結構，
因而使得骨細胞在初期附著生長的識別期長。因此，縮短與骨細胞附著生長的識別期，讓
骨細胞在生長初期及後續成長能形成一堅固的交織，衍然成為重要的議題。 
骨整合 (Osseointegration)成功的植體中，植體與骨頭間分隔著一層蛋白多醣體
(Proteoglycan)，癒合失敗的植體周圍是由不穩固的軟組織所包圍，所以骨整合不論成功或
失敗，植體與骨骼間都隔著一層堅硬度較低的非骨質界面，當施力於植體上，植體會因骨
整合程度不同而有不同程度的移動[1]，也就是說，骨整合較差的植體，因其周圍軟組織較
多，植體穩固度較差，在某一施力範圍內，植體動搖度會隨外力增加而增加，當施力超過
此一範圍，植體移動度會與外力呈現非線性急遽增加關係，導致植體脫離失效。由於骨整
合成功的基礎在於植體與骨組織間的穩固程度，因此可分為植體剛植入時的初期穩固度
(Primary stability)和日後骨整合形成的後期穩固度(Secondary stability)，初期的穩固度階段
屬於機械性嵌合，後期組織瘉合階段則為骨整合結果。若初期的穩固度不夠時，當植體受
力時就會產生微移動(Micromotion)[2]，而微移動超過某一個限量時，將可能破壞骨整合的
進行，使植體被纖維組織包覆而導致失敗[3]，故影響植體初期穩固的二個因素：(1)骨骼和
植體接觸面積，在比較緻密的皮質骨上其穩固度較好。(2)咬合力傳達到植體與組織界面間
的狀況，過載的咬合力會使得植體移動，無法進行骨整合。至於後期穩固度，是指骨細胞
在植體與骨組織界面間產生了再生(Regeneration)和重塑(Remodeling)作用，這兩種作用會改
變骨骼的吸收與成形，骨塑形(Modeling)是指吸收和成形獨立發生，會造成骨骼外部形狀和
尺寸的改變；骨重塑(Remodeling)是指吸收與成形同時發生，骨骼內部進行結構調整，不改
變外在形狀與尺寸，是一種對周圍環境變化的適應性調整。當這兩種作用發生時就會增加
植體穩固度，一旦骨頭在植體的界面形成，骨質增加則植牙的成功率就會增加。 
因此成功的植入物表面工程設計重點在使植入物表面得以控制蛋白質吸收的能力以及
接續吸引成骨母細胞附著的能力。植入物表面吸收蛋白質的能力取決於材料的生物特性如
化性、電荷狀態、潤濕性和表面形貌。以鈦金屬表面化學特性而言，只要鈦金屬單純接觸
空氣或水，就可以在表面天然形成二氧化鈦(Titanium dioxide, TiO2)氧化層。在植入體內後，
氧化層會與體內水分子結合，形成-O-及-OH－，呈帶弱負電區域。因此這氧化層提供了鈦金
屬一動態屏障避免腐蝕，同時也促進磷酸鈣晶體，蛋白質及骨細胞的鍵結。在一些研究[4-8]
指出，由於 TiO2 與水分子結合會形成 Ti(OH)，且在碰觸到人體體液時，由於體液 pH 7.4
為弱鹼性，大於 TiO2 等電位點 pH≒6.6，因此會在 TiO2 表面形成帶弱負電區域的 Ti(OH)
和 TiO－。而 TiO2 本身所產生之自由基會吸附蛋白質和 Ca＋、PO43－而形成類骨之磷灰石，
誘導細胞進行鍵結及生長，因而使得 TiO2 有著良好的生物活性與相容性[9]。文獻[7,8,10,11]
亦證實，將 TiO2 浸泡至內含類似人體血漿之離子濃度之模擬體液(Simulated body fluid, SBF)
中，確實可促使磷酸鈣之沉積。 
鈦金屬天然氧化層已經有相當程度的骨細胞相容性，但其表面形貌近似鈦金屬原材且
呈非晶結構，所以骨細胞在初期附著生長時需要較久的識別期，也造成植入手術病患需更
久的癒合等待期。是故本研究將透過新興的微弧氧化處理技術(Micro-arc oxidation, 簡稱
MAO 或 Plasma electrolytic oxidation, 簡稱 PEO)於在鈦金屬表面產生 TiO2 多孔洞形態，以
改善蛋白質及骨細胞的親合力，達到成功的骨增生鍵結，期許此一表面處理技術能為牙科
鈦金屬植入材的應用挹注新生命。 
 6
有鑑於現今社會老年人口的比例快速成長，需要以人工材料來置換缺損或受傷的組織
之需求愈形加重，特別是用來置換缺損的硬組織方面，例如人工髖關節(Artificial hip joint)、
牙科植體(Dental implant)等[37]。且由於將鈦金屬植體植入體內與周圍骨組織鍵結及骨整合
(Bone intergration)的時間需長達好幾個月，因此如何促進植入金屬與骨頭的整合能力和縮短
癒合(Healing)的時間，以及改善硬組織與金屬植體間的固位性(Fixation)，自然成為本研究
的終極標的。 
如何在鈦金屬植入物表面製造出更相容於骨組織的議題雖然不斷有新的構想；從早期
使用熱噴塗將 HA 附著在鈦金屬的作法[38-42]，到使用傳統陽極處理(Anodizing)生成 TiO
於鈦金屬表面[43-46]，或是用電漿輔助擴散工程(Plasma-enhanced diffusion)來獲得氧化物及
氮化物於鈦金屬表面[47,48]，皆可看到鈦金屬表面工程對於骨組織相容性的重要性。唯上
列揭櫫之表面工程或手段皆有其缺失，例如 HA 噴塗最被詬病之處是在植入病患一段時間
後，雖然 HA 與母體骨細胞有良好的界面，卻容易在 HA 塗層和鈦金屬之間造成脫層。而
使用電漿輔助製程，雖在電漿輔助之下得以實現堅實的表面氮化或氧化層，鈦金屬基材卻
因擴散的高溫作用使晶粒粗化而降低機械強度。至於傳統陽極處理因酸性電解液的使用導
致製程對環境的不友善，且所得之氧化層與組織之相容性仍有不足之處。因此 MAO 表面
改質技術就成為當仁不讓的骨組織相容性表面改質技術。是以本研究將利用 MAO 製程在
生長速率快及基材間的附著力極佳[49]的優勢前提下，期能於鈦金屬表面製備出具高造骨特
性的 TiO2 鍍層。 
 
 8
屬管上，來增加成骨細胞親合附著的功能[64]。該成功案例在商品化的可能性上可說是微乎
其微，但卻代表了此一植入材表面工程領域的無所不用其極。 
至於基材的選擇上，α-Ti 雖然比重小、抗潛變性佳，但延展性與鍛造性較差；α+β-Ti
雖然強度佳、高溫性質優異，但楊氏模數仍遠大於骨頭[65]；β-Ti 則由於其楊氏模數小於 α-Ti
及 α+β-Ti，同時也具有優良的冷加工性和強度，因此逐漸被發展成低剛性材料[66]。有鑑
於 α-Ti 及 α+β-Ti 表面改質技術已有多方面的研究與探討[67,68]，反觀 β-Ti 優異延展性、鍛
造性佳及加工性良好等優勢，其研究卻仍乏善可陳，是故本計畫擬利用 β-Ti 楊氏模數小於
α-Ti 及 α+β-Ti 的優點，以 MAO 進行表面改質，期能生成具生物相容性的 TiO2 鍍層，有效
提升 β-Ti 金屬植入材與自體骨間的融合速度，縮短植入材在患者體內的痊癒時間，降低鈦
金屬植入材的製造成本，為生醫鈦金屬植入材另啟一扇窗。 
 
 10
 
 
圖 3 本研究所使用之微弧設備 
 
 
圖4 微弧處理設備與冷卻裝置示意圖 
 
表1 本研究之製程參數 
參數 數值 
電解液 磷酸二氫鈉 
電解液濃度(M) 0.05 
電解液 pH 值 9.2 
陽極試片(mm2) β-Ti 基材(20×20) 
輔助電極(mm2) ASIS 304 不銹鋼(40×90) 
攪拌方式 磁石 
放電電壓(V) 脈衝電源 9500 μs：500 μs/350 及 450 
微弧處理時間(min) 20 
電解液溫度(oC) 25 
 
 12
圖 5 β-Ti 經 MAO 處理、施以(a)350 V 放電電壓所得銳鈦礦相及(b) 450 V 放電電壓所得金
紅石相二氧化鈦鍍膜之晶體結構及截面與表面形貌 
 
微弧氧化層之表面物性 
而由表 2 可知，經微弧氧化處理前後之β-Ti 其組成成分 Cr、Al 及 Fe 之含量有明顯減
少的趨勢，推測其原因為 TiO2 的晶體結構限制了這些元素固溶於氧化層的能力所致。然而，
電解液中之 P 及 Na 元素則有大幅增加趨勢，預估將可使材料具備生物活性進而誘導骨質
生成[69]。 
表 2 經微弧氧化處理前後之試片表面元素組成分析表 
Element (at %) Material Ti Cr Al Fe P Na O 
β-Ti alloy 80.17 12.10 6.59 1.14 0 0 0 
MAO treated 18.20 1.65 1.03 0 8.23 0.39 70.5
 
微弧氧化層之電化學特性 
本研究探討β-Ti 合金和經微弧氧化處理後之β-Ti 合金試片的電化學分析，以瞭解其在
可能的醫療環境中之腐蝕情況。如果能夠了解 TiO2 鍍膜在醫療的環境以及人體中是否會發
生「腐蝕與電化學反應」，將有助於明白此材料在醫療器材上之可應用程度。而選以放電電
壓為 350 V 和 450 V 之微弧氧化處理試片(銳鈦礦相和金紅石相結構之 TiO2 鍍層)進行電化
學特性分析。 
而本研究採用之電化學分析為三極式量測，以β-Ti 合金試片為工作電極(WE)，白金線
作為輔助電極(AUX)，標準 Ag/AgCl 電極則為參考電極(REF)；工作溫度為室溫；電解質溶
液為生理食鹽水和 Hank’s solution。使用恆電位儀和交流阻抗儀量測其開路電位(OCV)、循
環伏安(CV)、交流阻抗分析(EIS)以及利用感應耦合電漿光譜儀(ICP-OES)進行金屬元素釋出
分析，並以 SEM 觀察試片經電化學分析後之微觀形貌。 
圖 6 分別為β-Ti 原材和經微弧氧化處理後之β-Ti 試片於生理食鹽水和 Hank’s solution
內之開路電位圖。由圖 6 (a)於生理食鹽水測試環境中可知，β-Ti 原材之開路電位隨著時間
之增加，而有些許增加之趨勢，此結果顯示出β-Ti 原材本身即具有一定的抗腐蝕能力，此
乃β-Ti 原材本身於潮濕環境下即會產生緻密鈍化膜(Passive layer)所致。而經過微弧氧化處
理之β-Ti 試片其開路電位遠高β-Ti 原材，且亦會隨著時間之增加而也有些許上升之趨勢，
其表示經微弧氧化處理後之β-Ti 試片其抗腐蝕能力遠優於β-Ti 原材。此乃因β-Ti 經微弧氧
化後於表面生成 TiO2 鍍層，由於鍍層本質為陶瓷材料所致，使經微弧氧化後之β-Ti 具有良
好之抗腐蝕能力。由圖中亦可發現，經微弧氧化處理放電電壓 450 Vβ-Ti 試片之開路電位高
於放電電壓 350 V β-Ti 試片，意即金紅石相 TiO2 鍍層比銳鈦礦相鍍層具有更優異之抗腐蝕
能力，其最初的開路電位為+0.49689 V (vs Ag/AgCl)，並且隨著時間穩定上升，在 2 h 後的
開路電位增為+0.56122 V (vs Ag/AgCl)。圖 6 (b)於 Hank’s solution 測試環境中可知，其與生
理食鹽水測試環境中具相同趨勢，即β-Ti 原材之開路電位隨著時間之增加，而有些許增加
之趨勢。而經過微弧氧化處理之β-Ti 試片其開路電位遠高β-Ti 原材，且亦會隨著時間之增
加而也些許上升之趨勢，表示經微弧氧化處理後之β-Ti 試片其抗腐蝕能力遠優於β-Ti 原
材。然而在微弧氧化處理放電電壓 450 V β-Ti 試片之開路電位，其初期雖略低於放電電壓
350 V β-Ti 試片，但當試驗時間經過 5913 秒後，其開路電位則高於放電電壓 350 V β-Ti 試
片，故其亦表示金紅石相 TiO2 鍍層比銳鈦礦相鍍層具有更優異之抗腐蝕能力，其最初的開
 14
 
圖 6 β-Ti 原材和經微弧氧化處理後之 β-Ti 試片於(a)生理食鹽水和(b) Hank’s solution 內之開
路電位圖 
 
 
圖 7 β-Ti 原材和經微弧氧化處理後之 β-Ti 試片於(a)生理食鹽水和(b) Hank’s solution 環境中
之循環伏安圖 
 
 
圖 8 β-Ti 原材和經微弧氧化處理後之 β-Ti 試片於(a)生理食鹽水和(b) Hank’s solution 環境中
之 Bode 圖 
 
表 3 Bode 圖計算出之電容與極化阻抗表 
 16
 
圖 10 (a) β-Ti 原材和分別於(b)放電電壓 350 V、微弧處理時間 20 min 及(c)放電電壓 450 V、
微弧處理時間 20 min 下微弧氧化處理所得鍍膜試片於 Hank’s solution 環境中之表面腐蝕形
貌 
 
微弧氧化後鈦植入材之骨母細胞相容性 
本研究係以 MC3T3-E1 造骨母細胞為試驗細胞，以培養用玻片(Cell culture glass)作為
對照組基準片，分析α-Ti 原材、β-Ti 原材以及微弧氧化處理後之β-Ti 試片的細胞貼附、增
生和分化能力，並進行造骨特性試驗，藉以觀察其骨細胞相容性。選以放電電壓 350 V 所
得銳鈦礦相TiO2鍍層和放電電壓 450 V所得金紅石相結構TiO2鍍層試片進行骨細胞相容性
試驗。 
圖 11 為α-Ti 原材、β-Ti 原材及經微弧氧化處理之β-Ti 試片之(a)細胞貼附、(b)細胞增
生、(c)細胞分化(ALP activity)、(d) OPN、(e) OCN 及(f)鈣之 mRNA 表現量所呈現之骨細胞
相容性指標圖形。由圖 11 (a)細胞貼附之數據中可發現：β-Ti 原材的貼附成效高於α-Ti 原
材，而經過微弧氧化處理之β-Ti 試片貼附成效最高可超出α-Ti 及β-Ti 將近 50%。同時於圖
11 (b)及(c)可發現：微弧氧化處理過之β-Ti 試片不論是增生能力或是代表分化能力的 ALP 
activity 亦都呈現大幅度的提升。綜合上述成果顯示，β-Ti 原材本身的骨細胞相容性已經高
於α-Ti 原材，而經微弧氧化處理所得之β-Ti 試片更是明顯地提升其骨細胞相容性將近
50~70%，即經過微弧氧化處理之β-Ti 試片確實能夠有效縮短骨細胞在初期附著生長的識別
期及促進骨母細胞成熟分化。然而前三項指標只能片面證明微弧氧化處理所得之β-Ti 試片
具有良好骨細胞相容效應，卻無法指證出其能促進骨母細胞發揮造骨作用。因此藉由圖 11 (d) 
OPN、(e) OCN 及(f)鈣之 mRNA 的表現量所呈現的數據明確顯示，經微弧氧化處理之β-Ti
試片確實可大幅提升骨細胞外間質 OPN 及 OCN 含量，而鈣之 mRNA 含量亦呈現相同的趨
勢變化，茲可證明造骨作用持續進行。 
 18
 
圖 11 β -Ti 原材和經微弧氧化處理之β-Ti 試片所得銳鈦礦相及金紅石相 TiO2 鍍層試片所進
行之(a)細胞貼附及(b)增生試驗所得之 SEM 細胞形貌 
 
 20
參考文獻 
[1] H. Chavez, L. F. Ortman, R. L. DeFranco and J. Medige, “Assessment of oral implant 
mobility”, Journal of Prosthetic Dentistry, 70 (1993) 421-426. 
[2] J. B. Brunski, The Influence of Force, Motion and Related Quantities on the Response of 
Bone to Implants, NY: Raven Press Ltd., (1998) 7-21. 
[3] J. G. Heller, T. Bradley, M. S. Estes and A. Diop, “Biomechanical study of screw in the 
lateral masses: variables affecting pull-out resistance,” Journal of Bone and Joint Surgery, 
78 (1996) 1315-1321. 
[4] P. G. Laing, A. B. Jr. Ferguson and E. S. Hodge, “Tissue reaction in rabbit muscle exposed to 
metallic implants”, Journal of Biomedical Materials Research, 1 (1967) 35-149. 
[5] K. E. Healy and P. Ducheyne, “Oxidation kinetics of titanium film in model physiologic 
environments”, Journal of Colloid and Interface Science, 150 (1992) 404-417. 
[6] P. A. Maeusli, P. R. Bloch, V. Geret and S. G. Steinemann, “Surface characterization of 
titanium and titanium alloys”, Advances in Biomaterials, 6 (1986) 57-62. 
[7] C. M. Lin and S. K. Yen, “Biomimetic growth of apatite on electrolytic TiO2 coatings in 
simulated body fluid”, Materials Science and Engineering: C, 26 (2006) 54-64. 
[8] J. M. Wu, F. Xiao, S. Hayakawa, K. Tsuru, S. Takemoto and A. Osaka, “Bioactivity of 
metallic biomaterials with anatase layers deposited in acidic titanium tetrafluoride solution”, 
Journal of Materials Science: Materials in Medicine, 14 (2003) 1027-1032. 
[9] N. Huang, P. Yang and X. Cheng, “Blood compatibility of amorphous titanium oxide films 
synthesized by ion beam enhanced deposition”, Biomaterials, 19 (1998) 771-776. 
[10] T. Sonoda and M. Kato “Topographic fidelity of Ti-O film deposited onto Ti-6Al-4V alloy 
substrate to its surface by reactive DC sputtering”, Materials Research Bulletin, 32 (1997) 
1419-1426. 
[11] Z. Xuebin, H. Minhui and D. Chuanxian, “Bond strength of plasma-sprayed 
hydroxyapatite/Ti composite coatings”. Biomaterials, 21 (2000) 841-849. 
[12] S. D. Cook, J. F. Kay, K. A. Thomas and M. Jarcho, “Interface mechanics and histology of 
titanium and hydroxylapatite-coated titanium for dental implants applications”, The 
International Journal of Oral and Maxillofacial Implants, 2 (1987) 15-22. 
[13] T. Albreksson, G. Zarb and A. R. Eriksson, “The long-term efficacy of currently used dental 
implant; A review and proposed criteria of success”, The International Journal of Oral and 
Maxillofacial Implants, 1 (1986) 11-15. 
[14] G. R. Parr, L. K. Gardner and R. W. Toth, “Titanium: the mystery metal of implant 
dentistry”, The Journal of Prosthetic Dentistry, 54 (1985) 410-414. 
[15] R. J. Solar, S. R. Pollack and E. Korostoff, “In vitro corrosion testing of titanium surgical 
implant alloys: an approach to understanding titanium release from implants”, Journal of 
Biomedical Materials Research, 13 (1979) 217-250. 
[16] T. Rae, “The biological response to titanium and titanium-aluminium-vanadium alloy 
particles II. Long-term animal studies”, Biomaterials, 7 (1986) 37-40. 
[17] S. Takemoto, M. Hattori, M. Yoshinari, E. Kawada, K. Asami and Y. Oda, “Corrosion 
behavior and surface characterization of Ti-20Cr alloy in a solution containing fluoride”, 
 22
of guided tissue regeneration on dehisced hydroxylapatite-coated and titanium endosseous 
implant surfaces:  A pilot study”, The International Journal of Oral and Maxillofacial 
Implants, 6 (1991) 294-303.  
[36] T. E. Rams and W. E. Robert, “Clinical and microbiological findings on newly inserted 
hydroxyapatite-coated and pure titanium human dental implants”, Clinical Oral Implants 
Research, 2 (1991) 121-127. 
[37] M. Niinomi, “Review: Recent research and development in titanium alloys for biomedical 
applications and healthcare goods”, Science and Technology of Advanced Materials, 4 
(2003) 445-454. 
[38] P. Cheang and K. A. Khor, “Thermal spraying of hydroxyapatite (HA) coatings-effects of 
powder feedstock”, Journal of Materials Processing Technology, 48 (1995) 429-436. 
[39] P. Cheang and K. A. Khor, “Addressing processing problems associated with plasma 
spraying of Hydroxyapatite coatings”, Biomaterials, 17 (1996) 537-544. 
[40] C. H. Quek, K. A. Khor and P. Cheang, “Influence of processing parameters in the plasma 
spraying of hydroxyapatite Ti-6Al-4V composite coatings”, Journal of Materials Processing 
Technology, 89-90 (1999) 550-555. 
[41] H. Li, K. A. Khor and P. Cheang, “Titanium dioxide reinforced hydroxyapatite coatings 
deposited by high velocity oxy-fuel (HVOF) spray”, Biomaterials, 23 (2002) 85-91. 
[42] G. L. Darimont, R. Cloots, E. Heinen, L. Seidel and R. Legrand, “In vivo behaviour of 
hydroxyapatite coatings on titanium implants: a quantitative study in the rabbit”, 
Biomaterials, 23 (2002) 2569-2575. 
[43] J. Pan, D. Thierry and C. Leygraf, “Electrochemical impedance spectroscopy study of the 
passive oxide film on titanium for implant application”, Electrochemica Acta, 41, 7/8 (1996) 
1143-1153. 
[44] M. Fini, A. Cigada, G. Rondelli, R. Chiesa, R. Giardino, G. Giavaresi, N. N. Aldini, P. 
Torricelli and B. Vicentini, “In vitro and in vivo behaviour of Ca- and P-enriched anodized 
titanium”, Biomaterials 20 (1999) 1587}1594. 
[45] Y. T. Sul, C. B. Johansson, Y. Jeong and T. Albrektsson, “The electrochemical oxide growth 
behaviour on titanium in acid and alkaline electrolytes”, Medical Engineering and Physics, 
23 (2001) 329-346 
[46] J. Pan, D. Thierry and C. Leygraf, “Electrochemical impedance spectroscopy study of the 
passive oxide film on titanium for implant application”, Electrochemica Acta, 41, 7/8 (1996) 
1143-1153. 
[47] K. T. Rie, T. Stucky, R. A. Silva, E. Leitao, L. Bordji, J. Y. Jouzeau and D. Mainard, 
“Plasma surface treatment and PAPVD on Ti alloys for surgical implants”, Surface and 
Coatings Technology, 74-75 (1995) 973-980. 
[48] E. Czarnowska, T. Wierzchon and A. Maranda-Niedba, “Properties of the surface layers on 
titanium alloy and their biocompatibility in in vitro tests”, Journal of Materials Processing 
Technology 92/93 (1999) 190-194. 
[49] P. A. Maeusli, P. R. Bloch, V. Geret and S. G. Steinemann, “Surface characterization of 
titanium and titanium alloys”, Advances in Biomaterials, 6 (1986) 57-62. 
[50] K. T. Bower, J. C. Keller, B.A. Randolph, D. C. Wick and C. M. Michasls, “Optimization of 
surfaces micromorphology for enhanced osteoblast responses in vitro”, The International 
Journal of Oral and Maxillofacial Implants, 7 (1992) 302-310. 
 24
[65] E. Eisenbarth, D. Velten, M. Müller, R. Thull and J. Breme, “Biocompatibility of 
β-stabilizing elements of titanium alloys”, Biomaterials, 25 (2004) 5705-5713. 
[66] M. Niinomi, “Recent metallic materials for biomedical applications”, Metallurgical and 
Materials Transactions. A, Physical Metallurgy and Materials Science, 33 (2002) 477-486. 
[67] E. Eisenbarth, J. Breme and H. Hildebrand, “Einfluss des vanadiumgehalts von 
Ti-Al-V-Legierungen auf zelladhäsion und biokompatibilität”, Biomaterialien, 2 (2001) 
203-210.  
[68] M. A. Khan, R. L. Williams and D. F. Williams, “The corrosion behaviour of Ti-6Al-4V, 
Ti-6Al-7Nb and Ti-13Nb-13Zr in protein solutions”, Biomaterials, 20 (1999) 631-637. 
[69] J. F. Shackelford, “Bioceramics-current status and future trends”, Materials Science Forum, 
293 (1999) 99-106. 
[70] M. Sevtina, L. Colombi Ciacchi, O. Meriani and A. De Vita, “Deposition of calcium ions on 
rutile (110): a first-principles investigation”, Acta Materialia, 49 (2001) 2169-2177. 
[71] H. M. Kim, F. Miyaji, T. Kokubo and T. Nakamura, “Preparation of bioactive Ti and its 
alloys via simple chemical surface treatment”, Journal of Biomedical Materials Research,  
32 (1996) 409-417. 
[72] X. X. Wang, S. Hayakawa, K. Tsuru and A. Osaka, “Improvement of bioactivity of 
H2O2/TaCl5-treated titanium after subsequent heat treatments”, Journal of Biomedical 
Materials Research, 52 (2000) 171-176. 
 
Micro-arc oxidation of β-titanium alloy: Structural characterization and
osteoblast compatibility
Hsien-Te Chen a,b, Ching-Hung Hsiao a, Han-Yun Long a, Chi-Jen Chung c,⁎, Chih-Hsin Tang d,
Keh-Chang Chen a, Ju-Liang He a
a Department of Materials Science and Engineering, Feng Chia University, 100 Wen-Hwa Road, Taichung 40724, Taiwan, ROC
b Department of Orthopaedic Surgery, China Medical University Hospital, 2 Yue-Der Road, Taichung 40447, Taiwan, ROC
c Department of Dental Laboratory Technology, Central Taiwan University of Science and Technology, 666, Buzih Road, Beitun District, Taichung 40601, Taiwan, ROC
d Department of Pharmacology, China Medical University,91 Hsueh-Shih Road, Taichung 40421, Taiwan, ROC
a b s t r a c ta r t i c l e i n f o
Available online 5 July 2009
Keywords:
β-titanium alloy
Micro-arc oxidation
Microstructure
Bone implant
The β-titanium alloys have recently become important in bone implant applications. In this study, micro-arc
oxidation (MAO) was used to modify the surface of β-titanium alloy (Ti–13Cr–3Al–1Fe) using NaH2PO4
solution as an electrolyte. The microstructure of the oxidized layer as a function of the applied voltage and
treatment time were investigated. The cellular adhesion, proliferation and alkaline phosphatase (ALP)
activity of MC3T3-E1 pre-osteoblast were measured to reveal the cell compatibility of the treated specimens.
The experimental results show that microstructure of the oxidized layer can be greatly affected by the
discharge voltage and treatment time during MAO treatment as α-titanium metal and α+β titanium are.
The oxidized layer can gradually increase its thickness, pore size and surface roughness as a function of the
discharge voltage and treatment time, which at the same time increases the rutile phase constituent. The
osteoblast cell compatibility presented by the treated specimens is increased but less sensitive to the process
parameters, even though the associated difference in morphology and crystalline form are found to be
tremendous.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
As a medical implant material, titanium metals have better
biocompatibility and mechanical properties than many other metallic
materials. By comparison, the α-titanium and α+β dual-phase
titanium alloys (e.g. Ti–6Al–4V), as opposed to β-titanium alloys are
extensively utilized in biomedical materials. The Young's modulus (E)
of α-titanium is 100 GPa; though close to that of a human skeleton
(E=18 GPa) [1], yet the poor abrasion resistance limits its usage for
implants without being subjected to signiﬁcant stress or surface
friction. The harmful vanadium element presented in Ti–6Al–4V
tending to release into human body [2,3] has let the development of
new α+β titanium alloys such as Ti–6Al–7Nb [4,5] and Ti–5Al–2.5Fe
[5,6]. The Young's modulus for the above two examples are 114 GPa
and 112 GPa, respectively; much higher than that of a human skeleton
and prone to induce the stress shielding effect [7]. Knowing the
advantages of β-titanium alloys—high strength, low Young's modulus
(E=85–90 GPa), excellent corrosion resistance and free from vana-
dium [8]—many researchers have begun to focus on β-titanium alloys
as biomedical implant materials (notably Ti–15Mo [9] and Ti–13Nb–
13Zr [10]).
Although the natural oxide layer grown on titanium metal surface
has good biocompatibility with bone cells, it appears in non-crystal-
line form that the identiﬁcation for a bone cell in the initial cell-
attachment stage is long. Reducing this period, as well as forming ﬁrm
bone-implant integrity is important. Surface treatments on titanium
metal include thermal hydroxyapatite spray [11,12], anodizing the
titanium surface to grow an oxidation layer [13,14] and then employ-
ing an alkali treatment to generate a calcium phosphate coating [15].
Among the many surface treatment technologies, micro-arc oxidation
has received the most attention. It uses an electrochemical technique
to cover the anode surface with a titania oxidation layer that can be
crystalline, rough, porous and biocompatible with strong adhesion to
the substrate [16,17].
Many β-titanium alloys have excellent biomechanical properties
and corrosion resistance, yet progress in micro-arc oxidizing these
materials is not reported in the literature. Here, a new β-titanium alloy
(Ti–13Cr–3Al–1Fe with E=85–90 GPa) will be subjected to MAO to
produce thin ﬁlm TiO2 that is expected to have compatibility with
osteoblast cells. The microstructure of TiO2 and its morphological
effect on biocompatibility will also be investigated. Opportunities for
applying MAO technology to β-titanium alloys in orthopedic implants
are also sought.
Surface & Coatings Technology 204 (2009) 1126–1131
⁎ Corresponding author. Postal address: Department of Dental Laboratory Technology,
Central Taiwan University of Science and Technology, 666 Buzih Road, Beitun District,
Taichung 40601, Taiwan, ROC. Tel./fax: +886 4 24519053.
E-mail address: cjchung@seed.net.tw (C.-J. Chung).
0257-8972/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.surfcoat.2009.06.043
Contents lists available at ScienceDirect
Surface & Coatings Technology
j ourna l homepage: www.e lsev ie r.com/ locate /sur fcoat
output is maintained at constant voltage. MAO is carried out ﬁve times
to obtain ﬁve specimens with the same oxidizing condition and
preceded further for microstructure characterization and cell compat-
ibility. TheMAO treatment parameters are shown in Table 1, where the
discharge voltage and treatment time are the two variables for
preparing the oxidized TiO2 layer.
The prepared specimen was subjected to grazing incidence X-ray
diffractometer (XRD) using Cu Kα (λ=1.5405 nm) with incident angle
ﬁxed at 2° for crystal structure characterization. A ﬁeld emission
scanning electronmicroscope (FESEM) was used to observe the surface
and cross-sectional morphology of the MAO layer on specimens. The
average roughness (Ra) was measured using a surface roughness tester.
A murine pre-osteoblastic cell line MC3T3-E1 was obtained from
Riken Cell Bank (Tsukuba, Japan). Cells were plated in test specimens
and incubated for 30 min at 37 °C to allow adhesion. After removing
the non-adherent cells, the test specimens were read with a CytoFluor
2300 ﬂuorescence plate reader (Millipore) for determining cell
adhesion performance. Cell proliferation was measured using MTT
(3-[4,5-dimethylthiahiazo-2-yl]-2,5-diphenytetrazolium bromide)
assay after 48 h where a microplate reader (Bio-Tek, Winooski, VT)
Fig. 2. SEM surface (left) and cross-sectional (right) morphology of the oxidized layers treated with MAO at applied voltage of 350 V for treatment time (a) 10 min; (b) 20 min;
(c) 30 min; and (e) 40 min.
1128 H.-T. Chen et al. / Surface & Coatings Technology 204 (2009) 1126–1131
ability to use β-titanium alloy to grow an oxidized layer with arbitrary
anatase/rutile phase composition in it by manipulating discharge
voltage and treatment time.
3.2. Cell compatibility of the oxidized TiO2 layer
The cell compatibility test includes cellular adhesion, proliferation
and ALP activity of the specimens treated at various discharge voltage
and treatment time are shown in Figs. 5 and 6. Cell adhesion, it could
be seen that the MAO treated β-titanium specimens exhibit signiﬁ-
cantly higher cell attachment than that on bare α-titanium as well as
bare β-titanium (Pb0.001). In addition, it is clear that β-titanium
demonstrates much higher cell proliferation than α-titanium, indicat-
ing the cell compatibility of bare β-titanium is much better than that
of α-titanium (Pb0.001). Meanwhile, the proliferation of MC3T3-E1
cells observed in the β-titanium specimen after MAO treatment under
different conditions is far greater than bare β-titanium (Pb0.001). For
the results of cell differentiation test also shown in Figs. 5 and 6, the
ALP activity for bare β-titanium and MAO treated β-titanium is
substantially higher than that for α-titanium (Pb0.001). It is worth
noting that all performance in cellular adhesion, proliferation and
ALP activity of each MAO treated specimen in our study appeared the
same—regardless of the discharge voltage and treatment time. This
shall be due to the fact that the TiO2 oxidized layer accelerates the cell
adhesion in the very beginning of cell culture as expected. Literatures
suggested that TiO2, regardless of anatase or rutile in theMAO-formed
ﬁlm seems to be bioactive [16,27,28]. The in vitro bioactivity is
ascribed to Ti–OH group or negatively charged surface as well as to an
epitaxial effect of the anatase structure [27,29,30]. The driving force
for adsorption on the hydrated oxide surface is identiﬁed in the
electrostatic interaction between the Ca+ complex and negatively
charged deprotonated sites present on the hydrated TiO2 (110) surface
[28]. As to the increased overall cell compatibility as a function of
discharge voltage and treatment time in our study, an investigation
involving detailed microstructure characterization, in vitro cellular
calciﬁcation and mineralization analysis with in vivo histological
observations shall be further progressed.
The morphology of the MC3T3-E1 cells adhered on the specimens
for 30 min are shown in Fig. 7(a), (b) and (c) for culturing on bare β-
titanium, MAO treated specimen for 10 min and 40 min, respectively.
On bare β-titanium, the cells were in close contact with the specimen
and spread out uniformly over the surface, as shown in Fig. 7(a).
The morphology of the cells adhered on the MAO treated specimens
was not much different but the number of cell adhered on speci-
mens increased along with increasing the treatment time as shown in
Fig. 7(b) and (c). It is also seen that some cells in Fig. 7(b) and (c) are
actually undergoing proliferation, which seemed to be a collateral
evidence for the oxidized layer to accelerate cell attachment, and thus
early proliferation occurs. After culturing the cells for 48 h on bare β-
titanium, MAO treated specimen for 10 and 40 min, respectively, the
cells proliferate vigorously in all cases as shown in Fig. 7(d), (e) and
(f), with however much viable cells are observed in Fig. 7(e) and (f)
indicating that the cell proliferation is indeed beneﬁcial from the
accelerating cell attachment by the MAO treatment. By such
demonstration, the simple, controllable and cost-effective MAO
technique to form a bone cell compatible layer on β-titanium alloy
has been achieved. However the cell compatibility presented by the
treated specimens is less sensitive to the process parameters, even
though the associated difference in morphology and crystalline form
was found to be tremendous.
4. Conclusions
MAO technique has successfully been used in this study to grow
TiO2 on Ti–13Cr–3Al–1Fe β-titanium alloy. Microstructure of the
oxidized layer can be greatly affected by the discharge voltage and
treatment time. The oxidized layer can gradually increase the layer
thickness, pore size and surface roughness as a function of the
discharge voltage and treatment time, which at the same time
increases the rutile phase constituent. The osteoblast cell compat-
ibility presented by the treated specimens is increased but less
sensitive to the process parameters, even though the associated
difference in morphology and crystalline form is remarkable. This
could be ascribed to the lesser sensitive composition nature for cell
adhesion, to which the MAO oxidized layer contributes most and
Fig. 6. Cell viability of MC3T3-E1 cells cultured on various specimens. (a) α-titanium;
(b) β-titanium; and after MAO treated at 350 V for (c) 10 min; (d) 20 min; (e) 30 min;
and (f) 40 min. Results are expressed in relative activity. Pb0.001 as compared to bare
α-titanium and β-titanium substrate.
Fig. 5. Cell viability of MC3T3-E1 cells cultured on various specimens. (a) α-titanium;
(b) β-titanium; and after MAO treated at (c) 300 V; (d) 350 V; (e) 400 V; and (f) 450 V.
Results are expressed in relative activity. Pb0.001 as compared to bare α-titanium and
β-titanium substrate.
1130 H.-T. Chen et al. / Surface & Coatings Technology 204 (2009) 1126–1131
 Bioactive Coatings and Surface Biofunctionalization Printed 12/14/2009 
International Conference on Metallurgical Coatings and Thin Films, April 26, 2010 
Session: 
TS3-2-8 
Osteoblast Growth Affected by Micro-arc Oxidized β-titanium Alloy Abstract # 
291 
 
Author(s) Presenter Correspond
Hsien-Te Chen; Feng Chia University; China Medical University Hospital, Taiwan X  
Chi-Jen Chung; Central Taiwan University of Science and Technology, Taiwan  X 
Tsai-Ching Yang; Feng Chia University, Taiwan, R.O.C.   
Hsi-Kai Tsou; Feng Chia University; Taichung Veterns General Hospital, Taiwan   
Chin-Hsin Tang; China Medical University, Taiwan   
Keh-Chang Chen; Feng Chia University, Taiwan   
Ju-Liang He; Feng Chia University, Taiwan   
 
Abstract: 
β titanium alloys (β-Ti) are known to have excellent physical properties as well as biocompatibility and therefore 
considered as new generation metals for orthopedics and dental implants. For better osseous integration between 
the β-Ti and bone, this study aims to develop micro-arc oxidation (MAO) modified titanium oxide (TiO2) coating 
on β-Ti surface. Two commonly known crystal structures; anatase and rutile phase were formed on β-Ti by using 
sodium dihydrogen phosphate electrolyte. In-vitro tests including biocompatibility and bone formation 
performance using pre-osteoblast cell (MC3T3-E1) were carried out. The former includes cell adhesion, cell 
proliferation and ALP activity, while the later includes osteopontin (OPN), osteocalcin (OCN) and content of 
calcium messenger RNA (mRNA). Cell morphology was also observed to reveal the effect of MAO modification 
on the bone cell growth. In addition, MAO-modified β-Ti plate was embedded into the distal femur of Japanese 
white rabbits for 4, 8 and 12 weeks for evaluating its in-vivo performance.  
Experimental results show that the TiO2 coating can be grown and well-adhered on β-Ti. Crystal structure is 
strongly influenced by the applied voltage, where anatase phase was formed under low voltage instead of rutile 
phase under high voltage. Porous morphology of the TiO2 coating was obtained regardless of the crystal structure. 
By comparison, β-Ti shows better biocompatibility and bone formation performance than α-Ti, whist TiO2 
coating exhibits superior bone formation performance than β-Ti. In-vivo analysis shows similar trend as the 
results of in-vitro tests. It is also worth to note that rutile-containing TiO2 coating gives better biocompatibility, 
bone formation performance and in-vivo bone ingrowth. MAO process to produce rutile-containing TiO2 coating 
can therefore serve as a novel surface modification technique for β-Ti alloy implant and provide a well-
osteoconductive coating. 
 
Note: Requested an Oral Session. 
 
良好的生物相容性，但骨細胞在初期附著生長的
識別期較長。因此如何縮短識別期並促進骨細胞
生長，進而在初期及後續成長能形成一堅固的交
織，在生醫工程是ㄧ重要的議題。為解決上述的
問題，許多團隊深入探討二氧化鈦對應之骨細胞
相容性[3,4] 及生物相容性[5,6]等特性。 
為了獲得優異的骨細胞生長特性，許多表面
處理技術均投入對生醫鈦金屬進行研究，如：熱
噴塗氫氧基磷灰石[7,8]、陽極處理鈦金屬[9]及鹼
處理的方式被覆磷酸鈣[10]。在眾多的表面處理技
術中微弧氧化(Micro-arc oxidation, MAO)係將置
於電解液中的工件與輔助電極間給予一電位差，
使得工件表面出現微弧放電現象進而生長鍍膜，
所生成的鍍膜無須熱處理即具結晶性[11]、電解液
調節性高[12]、鍍膜相結構可調[13]、可強化與基
材間的附著力之多孔狀結構以及生長速率快
[13]；且冷卻系統在適當的控制下可進行常溫製
程，因此使得微弧氧化技術更受矚目。有研究指
出微弧氧化處理可在鈦金屬表面生成具有生物相
容性之二氧化鈦結構[11]，然而同時評估二氧化鈦
之銳鈦礦及金紅石兩種相結構之骨母細胞相容性
及造骨能力卻未曾被完整分析並探討。是故本研
究於β-Ti 合金基材上進行微弧氧化處理，製備出
銳鈦礦相(Anatase, A)及金紅石相(Rutile, R)兩種
代表性相結構的二氧化鈦鍍膜，進而以造骨母細
胞(MC3T3-E1 cell)進行體外試驗，詳細評估細胞
的相容性及造骨特性。 
 
二、材料與方法 
 
本研究使用之 β-Ti 基材為日本大同製鋼研發
之 β 型鈦合金(商品名：CA-Ti)，其化學組成為
Ti-13Cr-3Al-1Fe。微弧氧化設備示意圖如 Figure 1
所示。製程參數設定如 Table 1 所示。 
 
Figure 1 Schematic of MAO system used in this 
study. 
 
使用 Hitachi S-4800 場發射掃描式電子顯微
鏡 (Field emission scanning electron microscope, 
FESEM) 觀 察 鍍 膜 的 表 面 及 截 面 形 貌 。 以
Bruker-D8 X 光繞射儀(X-ray diffraction, XRD)對
氧化層進行低掠角晶體結構繞射分析。 
本研究所使用之細胞為 MC3T3-E1 造骨母細
胞，所有的體外試驗都以 β-Ti 裸材及α-Ti 裸材做
為對照之標準。 
Table 1 Parameters for micro-arc oxidation. 
Parameter Data 
Chemical composition Ti-13Cr-3Al-1Fe 
Electrolyte Sodium dihydrogen phosphate (0.05 M) 
Bath pH 9.2 
Applied voltage (V) 350, 450 
Oxidizing time (min) 20 
Substrate ( as anode) CA-Ti substrate (20 × 20 mm2) 
Cathode material Stainless steel (40 × 90 mm2) 
Bath stirring magnet stirrer 
Bath temp. (°C) 25°C 
 
細胞相容性試驗中的細胞貼附能力試驗係將
1×105 顆含有螢光染劑之造骨母細胞接種於試片
上，2 h 後利用磷酸緩衝食鹽水(Phosphate buffered 
saline, PBS)吸除未黏著之細胞後，在螢光儀下以
波長 450 nm 之螢光激發，量測螢光值以得知吸附
細胞數目之百分比。最後，細胞貼附之試片進行
SEM 細胞形態觀察。 
細胞相容性試驗中的細胞增生試驗是將
1×105 顆造骨母細胞接種於試片上，經過 48 h 的
培養，與濃度 0.5 mg/mL 之 MTT 作用 30 min 後，
利用 DMSO 溶出細胞內部的 MTT，再使用波長
550 nm 的 ELISA reader 量測 DMSO 的吸光值，並
計算細胞的增生數目。最後，細胞增生之試片進
行 SEM 細胞形態觀察。 
細胞相容性試驗中的細胞分化試驗是將
1×105 顆造骨母細胞接種於試片上，經 48 h 的培
養後，利用 Lysis buffer 溶出細胞內部蛋白質，並
添加鹼性磷酸脢(Alkaline phosphatase, ALP)受質
p-nitrophenol phosphate 與蛋白質中的 ALP 作用形
成 p-nitrophenol，經過 60 min 作用後，利用波長
405 nm 的 ELISA reader 量測其吸光值，以量測細
胞分化能力。 
造 骨 特 性 試 驗 是 先 以 qPCR(Real-time 
quantitative PCR)即時量測骨母細胞所生成骨橋蛋
白(Osteopontin, OPN)、骨鈣素(Osteocalcin, OCN)
及鈣之 mRNA(Messenger RNA)的表現量；並於
37°C 環境溫度下，骨母細胞經 48 h 培養後收集細
胞培養液並利用 ELISA 分析 OPN 及 OCN 蛋白含
量，以確認骨母細胞之生長功能是否正常，並驗
證其對造骨作用之影響。 
 
所得細胞 (a)貼附、 (b)增生、 (c)ALP activity、
(d)OPN、(e)OCN 及(f)鈣之 mRNA 表現量所呈現
之骨細胞相容性指標圖形。由 Figure 4(a)細胞貼附
之數據中可發現：β-Ti 的貼附成效高於 α-Ti，而
經過 MAO 處理過之 β-Ti 試片貼附成效最高可以
超出 α-Ti 及 β-Ti 將近 50 %。同時於 Figure 4(b)
及(c)可發現：MAO 處理過之 β-Ti 試片不管是增
生效率或是代表分化能力的 ALP activity 都呈現
大幅度的提升，這就表示經 MAO 處理所得二氧
化鈦鍍膜的確能夠促進骨母細胞成熟分化。 
 
Figure 4 In vitro cell test result of MC3T3-E1 for (a) 
cell adhesion, (b) cell proliferation, (c) ALP activity, 
(d) OPN, (e) OCN and (f) content of calcium 
messenger RNA for α-Ti, β-Ti and MAO treated 
specimen containing anatase and rutile phase, 
respectively. 
 
由此可知 β-Ti 本身的骨細胞相容性已經高於
α-Ti，然而經 MAO 處理所得之二氧化鈦鍍膜更是
明顯地提升骨細胞相容性將近 50~70%。然而前三
項指標只能片面證明 MAO 所得二氧化鈦鍍膜具
有良好骨細胞相容效應，卻無法指證出二氧化鈦
鍍膜能促進骨母細胞發揮造骨作用。因此藉由
Figure 4(d)OPN、(e)OCN 及(f)鈣之 mRNA 的表現
量所呈現的數據可知，二氧化鈦鍍膜確實可以大
幅提升骨細胞外間質 OPN 及 OCN 含量，而鈣之
mRNA 含量亦呈現相同的趨勢變化，可茲證明造
骨作用持續進行。有研究指出無論是銳鈦礦或是
金紅石本身都具有生物活性的特性[12,20,21]，相
信藉由 MAO 技術所製備出具結晶性之二氧化鈦
將可縮短了細胞貼附所需時間，致使細胞可以更
快速地在鍍膜表面上進行貼附呈現優異的骨細胞
分化效應。 
 
四、結論 
 
本研究以微弧氧化處理技術於 β-Ti 合金
(CA-Ti)表面成功製備出銳鈦礦相及金紅石相結構
之多孔狀二氧化鈦鍍膜，最後得出以下結論： 
(a) 鍍膜之晶體結構在較低的 350 V 放電電壓時
生成銳鈦礦相為主之二氧化鈦，而在較高的
450 V 放電電壓時則生成金紅石相結構為主
之二氧化鈦。不論生成何種相結構鍍膜皆呈
附著良好之多孔形貎。 
(b) MAO 處理所得二氧化鈦鍍膜的確能夠有效
促進骨母細胞的貼附、增生、分化及促進後
續之造骨作用。其中金紅石相二氧化鈦鍍膜
比銳鈦礦相有較佳的細胞相容性及造骨作
用。 
 
誌謝 
 
本研究承蒙行政院國家科學委員會研究計畫
(NSC 98-2218-E-166-001-)經費補助支持，特此致
謝。 
 
參考文獻 
 
[1] 黃信華，(2006)成功大學機械工程學系碩士
論文，4-5。 
[2] 謝聰斌，(2002)成功大學材料科學與工程學
系碩士論文，17-18。 
[3] X. J. Tao, S.J. Li, C.Y. Zheng, J. Fu, Z. Guo, Y 
L. Hao, R. Yang and Z.X. Guo (2009) Mater. 
Sci. Eng. C, 29: 1923-1934. 
[4] H. Tsuchiya, J. M. Macak, L. Muller, J. Kunze, 
F. Muller, P. Greil, S. Virtanen and P. Schmuki 
(2006) J. Biomed. Mater. Res. Part A, 77: 
534-541. 
[5] R. Carbone, I. Marangi, A. Zanardi, L. 
Giorgetti, E. Chierici, G. Berlanda, A. Podestà, 
F. Fiorentini, G. Bongiorno, P. Piseri, P.G. 
Pelicci and P. Milani (2006) Biomaterials, 27: 
3221-3229. 
[6] C. I. Vamanu, M. R. Cimpan, P. J. Høl, S. 
Sørnes, S. A. Lie and N. R. Gjerdet (2008) 
Toxicol. Vitro, 22: 1689-1696. 
[7] H. Li, K. A. Khor and P. Cheang (2002) 
Biomaterials, 23: 85-91. 
[8] G. L. Darimont, R. Cloots, E. Heinen, L. Seidel 
and R. Legrand (2002) Biomaterials, 23:  
2569-2575. 
[9] Y. T. Sul, C. B. Johansson, Y. Jeong and T. 
Albrektsson (2001) Med. Eng. Phys., 23: 
329-346. 
[10] J. Pan, D. Thierry and C. Leygraf (1996) 
Electrochemica Acta, 41: 1143-1153. 
2009 Int’l Conf. on Metallurgical Coatings and Thin Films心得報告 
                                                            
報告人：中臺科技大學/牙體技術系/副教授/鍾啟仁  
 
會議名稱：International Conference on Metallurgical Coatings and Thin Films, 
ICMCTF 2009 
會議時間：April 27~ May 1, 2009 
會議地點：Town and Country Hotel, San Diego, California, U.S.A. 
 
一、 出席緣由 
International Conference on Metallurgical Coatings and Thin Films (ICMCTF)
自 1974年起已經創辦 35屆，2009年第 36屆會議依舊選擇在加州聖地牙哥之城
鄉旅館(Town and Country Hotel)舉辦。該會議是美國真空協會的「先進表面工程
部」(American Vacuum Society, Advanced Surface Engineering Division)所主辦，
今年會期由 4/27/至 5/1/共 5 天。每年吸引全球約 400-500 人參加，可說是全球
最大的鍍膜科技研討會。台灣的學術界包括清華大學、交通大學、成功大學、
逢甲大學等知名學府出席這項盛會，今年台灣學術界鍍膜相關領域出席的人士
更勝以往，可知此會議越來越受國內學術界的重視。 
今年所發表之論文篇數超過 650 篇。而口頭報告的場次高達 420 場之多與
235篇壁報展示，包含近百位受邀演講的專家學者及世界各地的學者、專家、工
程師與管理者共聚一堂，在科學理論、技術及應用實務之間互相交換資訊心得。
會議中除了以口頭報告方式的技術性會議(technical session)外，還邀請學術及產
業界的知名人士就相關議題發表主題演說(Tutorials)。 
 
二、 會議經過 
在此感謝國科會的補助，使此次出席得以順利成行。本人於 4/26 當天搭乘
長榮航空 BR168班機離開台灣，飛抵洛杉磯之後隨即租車前往聖地牙哥。這次
ICMCTF大會依慣例把同性質的口頭報告和壁報展示歸類成幾個主題如下： 
A. Coatings for Use at High Temperature 
B. Hard Coatings and Vapor Deposition Technology 
C. Optical Thin Films 
D. Carbon and Nitride Materials: Synthesis-Structure-Property Relationships 
E. Tribology and Mechanical Behavior of Coatings and Thin Films 
F. Characterization: Linking Synthesis Properties and Microstructure 
G. Applications, Manufacturing, and Equipment 
H. New Horizons in Coatings and Thin Films 
大會的議程總共有 5天，如此眾多場次的講演不乏叫人激賞及學習之主題，
唯其平行多場之議程，只好忍痛割愛不少場次，選擇出席感到興趣的幾個場次。
其中德國學者O. Zimmer之「Trends and Applications of Cathodic Arc Evaporation」
明確指出陰極電弧蒸鍍設備所具備之強大性能，如靶材高離化率、高離子動能、
鍍膜附著性佳以及價格低廉等優勢。用以發展工具鍍及裝飾鍍尤其適合。而另
一位來自德國 Tuebingen 大學的 D. Stiens 發表「Properties and Tribological 
Behavior of CVD TiBN-coated Cutting Tools」。講者以 100Cr6及鋁材作為剪切目
標材料，利用所添加的硼含量變化以 Laser Raman Spectroscopy輔助分析得到摩
擦化學反應式，以獲得真實做動下所發生的反應變化。雪菲爾大學之 A. Yerokhin
以「Characterization of Ca- and P-containing PEO coatings on Ti substrates」發表演
說。講者成功以引入不同的鈣磷比(Ca / P ratio)致使鈦基材成長銳鈦礦及金紅石
相結構並可適度控制其含量比例。具有高含量鈣磷比的試片中投入細胞試驗中
可生成高細胞活性的成分，如氫氧基磷灰石及磷酸鈣，有效幫助細胞的生長。 
從 4/28日早上點開始至 4/29日下午五點於 Town and Country room及 San 
Diego room為廠商展示，今年參展的廠商超過 70 家，展出的內容包含應用、
檢測、冶金鍍膜與薄膜之特性分析及表面改質等內容十分豐富。申請人拜訪了
大部分廠家，索取了許多新的資料，也獲得不少產業及其他研討會訊息。 
其中有幾間廠家的內容相當吸引人，如：CEMECON公司所提出之 PVD濺
鍍設備不僅可以對於工件施予顏色作為辨識之用，也進一步提升其表面性質。
SULZER公司之Micro Alloyed Coatings (MAC)設備便是被設計為提升鋼件的腐
蝕特性、延展性及韌性的機台。NANOVEA-Division of Micro Photonics Inc.公司
也展出一系列的機台來檢測微機械性質、磨耗儀、非接觸式 3D輪廓儀及奈米機
械測試儀，其中奈米機械測試儀更換上鏡頭後亦可進行表面影像輸出並藉由軟
體的輔助下可對樣品表面進行溫度、應力及形貌的對比，功能相當強大。另外
也取得相關的研討會訊息，如：International symposium on sputtering & plasma 
processes (ISSP)及 International conference on plasma surface engineering in Asia 
(PSE)。這兩個研討會皆針對電漿製程所產出之材料系統進行探討，舉凡工業應
用之功能化薄膜及鍍膜、先進電漿製程與表面處理、電漿及離子之表面工程等
都為其主要議題。 
4/30 日下午五點開始的海報展示總共有 235 篇，可以發現專注於骨植入材
的研發及性質探討的論文為數不少。如來自瑞士材料測試及研究聯邦協會(Swiss 
Federal Institute for Materials Testing and Research)發表之 DP-10便針對脊椎椎間
盤的表面上以類鑽碳膜(Diamond-like-carbon, DLC)進行長期附著特性的揭露。英
國雪菲爾大學之 A. Yerokhin也於 ER-25發表「Micro-abrasion Wear Testing of 
PEO Coatings on 2024 Aluminum Alloy」探討藉由 PEO製程所產生的氧化層的磨
耗特性，以及 EP-27由葡萄牙 Universidade do Minho之 J.C. Sanchez-Lopez發表
「Ti(C,O,N)-Based Coatings for Biomedical Applications: Influence of Composition 
and Sturcutre on the Mechanical/Tribological and Biological Behavior」指出植入材
若產生過大的磨耗及磨屑將會造成微生物感染導致病變。藉此 J.C. 
